AGL 37.98 Decreased By ▼ -0.04 (-0.11%)
AIRLINK 205.50 Increased By ▲ 8.14 (4.12%)
BOP 9.58 Increased By ▲ 0.04 (0.42%)
CNERGY 6.33 Increased By ▲ 0.42 (7.11%)
DCL 9.05 Increased By ▲ 0.23 (2.61%)
DFML 37.50 Increased By ▲ 1.76 (4.92%)
DGKC 98.30 Increased By ▲ 1.44 (1.49%)
FCCL 35.90 Increased By ▲ 0.65 (1.84%)
FFBL 88.94 Increased By ▲ 6.64 (8.07%)
FFL 13.75 Increased By ▲ 0.58 (4.4%)
HUBC 129.42 Increased By ▲ 1.87 (1.47%)
HUMNL 13.70 Increased By ▲ 0.20 (1.48%)
KEL 5.46 Increased By ▲ 0.14 (2.63%)
KOSM 7.25 Increased By ▲ 0.25 (3.57%)
MLCF 45.28 Increased By ▲ 0.58 (1.3%)
NBP 60.80 Decreased By ▼ -0.62 (-1.01%)
OGDC 219.20 Increased By ▲ 4.53 (2.11%)
PAEL 40.72 Increased By ▲ 1.93 (4.98%)
PIBTL 8.47 Increased By ▲ 0.22 (2.67%)
PPL 199.00 Increased By ▲ 5.92 (3.07%)
PRL 39.45 Increased By ▲ 0.79 (2.04%)
PTC 27.27 Increased By ▲ 1.47 (5.7%)
SEARL 107.00 Increased By ▲ 3.40 (3.28%)
TELE 8.57 Increased By ▲ 0.27 (3.25%)
TOMCL 35.85 Increased By ▲ 0.85 (2.43%)
TPLP 13.70 Increased By ▲ 0.40 (3.01%)
TREET 24.38 Increased By ▲ 2.22 (10.02%)
TRG 61.15 Increased By ▲ 5.56 (10%)
UNITY 33.25 Increased By ▲ 0.28 (0.85%)
WTL 1.68 Increased By ▲ 0.08 (5%)
BR100 12,005 Increased By 278.4 (2.37%)
BR30 37,240 Increased By 863.2 (2.37%)
KSE100 112,429 Increased By 2916.1 (2.66%)
KSE30 35,478 Increased By 964.2 (2.79%)

GENEVA: The World Health Organization's vaccine advisers on Monday recommended people with weaker immune systems should be offered an additional dose of all authorised Covid-19 vaccines.

The UN health agency's Strategic Advisory Group of Experts on Immunisation (SAGE) also said over-60s who have been fully immunised with China's Sinovac and Sinopharm vaccine should be offered an additional third Covid-19 vaccine dose.

The experts stressed they were not recommending an additional so-called booster dose for the population at large.

Several Covid-19 vaccines have been given WHO approval for emergency use during the pandemic: Pfizer-BioNTech, Janssen, Moderna, Sinopharm, Sinovac and AstraZeneca.

AstraZeneca antibody drug important as preventative COVID-19 therapy

It is on the verge of deciding whether to give emergency use listing to India's Bharat Biotech jab.

SAGE held a four-day meeting last week to review the latest information and data on a range of vaccines for Covid-19 and other diseases.

"SAGE recommended that moderately and severely immunocompromised persons should be offered an additional dose of all WHO EUL (emergency use listing) Covid-19 vaccines as part of an extended primary series," the group said.

"These individuals are less likely to respond adequately to vaccination following a standard primary vaccine series and are at high risk of severe Covid-19 disease."

It also said that for people fully immunised with Sinovac and Sinopharm vaccines, an additional third dose of the same jab "should be offered to persons aged 60 and above".

A different vaccine "may also be considered based on vaccine supply and access considerations".

SAGE added that when implementing this recommendation, countries should initially aim at maximising two-dose coverage in that population, and thereafter administer the third dose, starting in the oldest age groups.

Comments

Comments are closed.